ArticleCancer medicine2025
Adherence to Breast Cancer Screening Guidelines Among Age-Eligible US Women: Findings From NHIS 2021.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Investigating the Average Glandular Dose and Exposure Parameters in Mammography Based on Compressed Breast Thickness and Imaging Projection: A Single-Centre Study in Jeddah, Saudi Arabia.Healthcare (Basel, Switzerland) · 2026Article
- Article
- Adherence to Breast Cancer Screening Guidelines Among Age-Eligible US Women: Findings From NHIS 2021.Cancer medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundDespite the proven benefits of early breast cancer detection in reducing mortality, adherence to breast cancer screening guidelines in the United States is suboptimal. In this study, we assessed the prevalence and factors associated with adherence to breast cancer screening guidelines.
methodsUsing nationally representative data from the National Health Interview Survey 2021, we included breast cancer screening-eligible women (aged 50-74). Descriptive statistics and population-weighted multivariable logistic regression were employed to examine breast cancer screening adherence per the United States Preventive Services Task Force guidelines, and its determinants in this population.
resultsOf the 6814 screening-eligible women included in this study, 76.4% adhered to breast cancer screening guidelines. Asians (adjusted odds ratio [AOR]: 0.59 (95% confidence interval [95% CI]: 0.42-0.83), p = 0.003), current cigarette smokers (AOR: 0.62 (95% CI: 0.50-0.76), p < 0.0001), individuals with a precollege educational attainment (less than high school [AOR: 0.60 (95% CI: 0.45-0.80), p = 0.0005] and high school or GED [AOR: 0.79 (95% CI: 0.66-0.94), p < 0.001]), those who reported a poor/fair health status (AOR: 0.71 (95% CI: 0.58-0.86), p = 0.0006), single/widowed/separated/divorced (AOR: 0.71 (95% CI: 0.61-0.82), p < 0.0001), and uninsured (AOR: 0.24 (95% CI: 0.18-0.32), p < 0.0001) women had lower odds of being adherent to breast cancer screening. Non-Hispanic Blacks (AOR: 1.81 (95% CI: 1.38-2.36), p < 0.0001), women who had a routine checkup in the past 2 years (AOR: 11.24 (95% CI: 7.31-17.29), p < 0.0001), and those with a personal cancer history (AOR: 1.44 (95% CI: 1.18-1.76), p = 0.0003) had higher odds of being adherent to breast cancer screening guidelines.
conclusionAdherence to breast cancer screening in the United States remained below the Healthy People 2030 goal, with important variations across sociodemographic, behavioral, and health-related factors. Public health actions such as integrating breast cancer awareness activities into smoking cessation programs, encouraging and equipping healthcare professionals to use culturally tailored interventions, and reinforcing community education about breast cancer and its prevention will help increase breast cancer screening adherence among US women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.